Business Context and Reporting Period
This Form 8-K reports on Health Sciences Acquisitions Corporation, a special purpose acquisition company (SPAC), for the period ending May 14, 2019. The filing details the effectiveness of the company's IPO registration statement on May 9, 2019, and the subsequent consummation of the IPO and a concurrent private placement on May 14, 2019.
Key Financial Metrics
- Gross Proceeds from IPO: $115,000,000 (from the sale of 11,500,000 units at $10.00 per unit, including full exercise of the over-allotment option).
- Gross Proceeds from Private Placement: $5,000,000 (from the sale of 10,000,000 private warrants at $0.50 per warrant).
- Total Capital Raised: $120,000,000.
- Funds in Trust: $115,000,000 deposited into a trust account for public shareholders.
- Warrant Exercise Price: $11.50 per whole share.
- Revenue, Profit, and Cash Flow: The filing text does not provide operating revenue, net income, or operating cash flow figures as the company is in the pre-business combination stage.
Material Changes
The primary material change is the transition from a private entity to a public company following the IPO. The company sold 10,000,000 units initially and an additional 1,500,000 units via the over-allotment option. Simultaneously, the company entered into definitive agreements including underwriting, warrant, trust, and administrative services agreements.
Outlook, Risks, and Unusual Items
- Private Warrant Terms: Private warrants sold to the sponsor are non-redeemable and exercisable on a cashless basis, differing from public warrants.
- Lock-up Provisions: Initial purchasers of private warrants agreed not to transfer or sell them until the completion of the initial business combination.
- Future Filings: An audited balance sheet reflecting the IPO proceeds is scheduled to be filed within 4 business days of consummation.
- Emerging Growth Company: The registrant has elected to be an emerging growth company.
Investor Verification Checklist
- Verify the final audited balance sheet to confirm the exact net proceeds after underwriting discounts and expenses.
- Review the Investment Management Trust Agreement to understand the terms governing the $115,000,000 held in trust.
- Confirm the specific redemption rights and expiration dates for the public warrants.
- Examine the Administrative Services Agreement for any ongoing fees payable to Health Sciences Holdings, LLC.